-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Downgrades scPharmaceuticals to Hold, Announces $6 Price Target

Benzinga·08/26/2025 18:01:14
Listen to the news
Craig-Hallum analyst Chase Knickerbocker downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold and announces $6 price target.